CoChat
Sign Up
Cited by 393

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Regulation of the MIR155 host gene in physiological and pathological processes

Elton, Terry S., Selemon, Helina, Elton, Shane M., Parinandi, Narasimham L.·2013·Gene
DOI 10.1016/j.gene.2012.12.009
Open this paper in CoChat — free account

Abstract

MicroRNAs (miRNAs), a family of small nonprotein-coding RNAs, play a critical role in posttranscriptional gene regulation by acting as adaptors for the miRNA-induced silencing complex to inhibit gene expression by targeting mRNAs for translational repression and/or cleavage. miR-155-5p and miR-155-3p are processed from the B-cell Integration Cluster (BIC) gene (now designated, MIR155 host gene or MIR155HG). MiR-155-5p is highly expressed in both activated B- and T-cells and in monocytes/macrophages. MiR-155-5p is one of the best characterized miRNAs and recent data indicate that miR-155-5p plays a critical role in various physiological and pathological processes such as hematopoietic lineage differentiation, immunity, inflammation, viral infections, cancer, cardiovascular disease, and Down syndrome. In this review we summarize the mechanisms by which MIR155HG expression can be regulated. Given that the pathologies mediated by miR-155-5p result from the over-expression of this miRNA it may be possible to therapeutically attenuate miR-155-5p levels in the treatment of several pathological processes.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.gene.2012.12.009

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 12 references

Research works printed but not linked: 154

  1. Adorno, 2009, A mutant-p53/Smad complex opposes p63 to empower TGF2-induced metastasis, Cell, 137, 87, 10.1016/j.cell.2009.01.039 · DOI
  2. Babar, 2012, Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma, Proc. Natl. Acad. Sci. U. S. A., 109, E1695, 10.1073/pnas.1201516109 · DOI
  3. Banerjee, 2010, Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells, Eur. J. Immunol., 40, 225, 10.1002/eji.200939381 · DOI
  4. Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
  5. Behm-Ansmant, 2006, RNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes, Genes Dev., 20, 1885, 10.1101/gad.1424106 · DOI
  6. Boss, 2011, A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice, J. Virol., 85, 9877, 10.1128/JVI.05558-11 · DOI
  7. Brennecke, 2005, Principles of microRNA-target recognition, PLoS Biol., 3, e85, 10.1371/journal.pbio.0030085 · DOI
  8. Brown, 2007, Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state, Nat. Biotechnol., 25, 1457, 10.1038/nbt1372 · DOI
  9. Bushati, 2007, microRNA functions, Annu. Rev. Cell Dev. Biol., 23, 175, 10.1146/annurev.cellbio.23.090506.123406 · DOI · Paper page
  10. Cawthorn, 2008, TNF-[alpha] and adipocyte biology, FEBS Lett., 582, 117, 10.1016/j.febslet.2007.11.051 · DOI
  11. Ceolotto, 2011, Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives, Am. J. Hypertens., 24, 241, 10.1038/ajh.2010.211 · DOI
  12. Ceppi, 2009, MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells, Proc. Natl. Acad. Sci. U. S. A., 106, 2735, 10.1073/pnas.0811073106 · DOI · Paper page
  13. Chang, 2011, Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155, Nat. Med., 17, 1275, 10.1038/nm.2459 · DOI
  14. Chendrimada, 2005, TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing, Nature, 436, 740, 10.1038/nature03868 · DOI
  15. Chendrimada, 2007, microRNA silencing through RISC recruitment of eIF6, Nature, 447, 823, 10.1038/nature05841 · DOI
  16. Cheng, 2011, microRNA-155 regulates angiotensin II type 1 receptor expression in umbilical vein endothelial cells from severely pre-eclamptic pregnant women, Int. J. Mol. Med., 27, 393
  17. Cobb, 2006, A role for Dicer in immune regulation, J. Exp. Med., 203, 2519, 10.1084/jem.20061692 · DOI
  18. Corsten, 2012, MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis, Circ. Res., 11, 415, 10.1161/CIRCRESAHA.112.267443 · DOI
  19. Costinean, 2006, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 103, 7024, 10.1073/pnas.0602266103 · DOI
  20. Cremer, 2009, MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response, PLoS One, 4, e8508, 10.1371/journal.pone.0008508 · DOI
  21. Doench, 2004, Specificity of microRNA target selection in translational repression, Genes Dev., 18, 504, 10.1101/gad.1184404 · DOI
  22. Dombkowski, 2011, In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis, Cancer Inform., 10, 13, 10.4137/CIN.S6631 · DOI
  23. Draheim, 2002, Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome, Am. J. Ment. Retard., 107, 201, 10.1352/0895-8017(2002)107<0201:DICDRB>2.0.CO;2 · DOI
  24. Eis, 2005, Accumulation of miR-155 and BIC RNA in human B cell lymphomas, Proc. Natl. Acad. Sci. U. S. A., 102, 3627, 10.1073/pnas.0500613102 · DOI
  25. Elton, 2010, Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins, RNA Biol., 7, 540, 10.4161/rna.7.5.12685 · DOI
  26. Elton, 2010, Cardiovascular disease, single nucleotide polymorphisms; and the renin angiotensin system: is there a microrna connection?, Int. J. Hypertens, 10.4061/2010/281692 · DOI
  27. Eulalio, 2007, Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing, Genes Dev., 21, 2558, 10.1101/gad.443107 · DOI
  28. Fabani, 2010, Efficient inhibition of miR-155 function in vivo by peptide nucleic acids, Nucleic Acids Res., 38, 4466, 10.1093/nar/gkq160 · DOI
  29. Fabian, 2012, The mechanics of miRNA mediated gene silencing: a look under the hood of miRISC, Nat. Struct. Mol. Biol., 19, 586, 10.1038/nsmb.2296 · DOI
  30. Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat. Rev. Genet., 2, 102, 10.1038/nrg2290 · DOI
  31. Forrest, 2010, Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation, Leukemia, 24, 460, 10.1038/leu.2009.246 · DOI · Paper page
  32. Fulci, 2007, Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia, Blood, 109, 4944, 10.1182/blood-2006-12-062398 · DOI
  33. Gardiner, 2006, The proteins of human chromosome 21, Am. J. Med. Genet., 142C, 196, 10.1002/ajmg.c.30098 · DOI
  34. Gatto, 2008, Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway, Nucleic Acids Res., 36, 6608, 10.1093/nar/gkn666 · DOI
  35. Georgantas, 2007, CD34+ hematopoietic stem–progenitor cell microRNA expression and function: a circuit diagram of differentiation control, Proc. Natl. Acad. Sci. U. S. A., 104, 2750, 10.1073/pnas.0610983104 · DOI
  36. Giraldez, 2006, Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs, Science, 312, 75, 10.1126/science.1122689 · DOI · Paper page
  37. Goi, 2006, Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an ‘atheroma-free model’: Down's syndrome, Int. J. Cardiol., 113, 427, 10.1016/j.ijcard.2005.10.019 · DOI
  38. Gottwein, 2007, A viral microRNA functions as an orthologue of cellular miR-155, Nature, 450, 1096, 10.1038/nature05992 · DOI
  39. Gottwein, 2011, Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines, Cell Host Microbe, 10, 515, 10.1016/j.chom.2011.09.012 · DOI
  40. Greene, 2008, Risk of vascular anomalies with Down syndrome, Pediatrics, 121, 135, 10.1542/peds.2007-1316 · DOI
  41. Gregory, 2005, Human RISC couples microRNA biogenesis and posttranscriptional gene silencing, Cell, 123, 631, 10.1016/j.cell.2005.10.022 · DOI · Paper page
  42. Griffiths-Jones, 2004, The microRNA Registry, Nucleic Acids Res., 32, D109, 10.1093/nar/gkh023 · DOI
  43. Grimson, 2007, MicroRNA targeting specificity in mammals: determinants beyond seed pairing, Mol. Cell, 27, 91, 10.1016/j.molcel.2007.06.017 · DOI · Paper page
  44. Guo, 2010, Mammalian microRNAs predominantly act to decrease target mRNA levels, Nature, 466, 835, 10.1038/nature09267 · DOI · Paper page
  45. Haasch, 2002, T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC, Cell. Immunol., 217, 78, 10.1016/S0008-8749(02)00506-3 · DOI
  46. Hon, 2007, The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression, Genome Biol., 8, R166, 10.1186/gb-2007-8-8-r166 · DOI
  47. Hu, 2010, HOXA9 regulates miR-155 in hematopoietic cells, Nucleic Acids Res., 38, 5472, 10.1093/nar/gkq337 · DOI
  48. Hui, 2009, Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues, Lab. Invest., 89, 597, 10.1038/labinvest.2009.12 · DOI
  49. Humphreys, 2005, MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function, Proc. Natl. Acad. Sci. U. S. A., 102, 16961, 10.1073/pnas.0506482102 · DOI
  50. Imaizumi, 2010, IFN-γ and TNF-α synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells, Am. J. Nephrol., 32, 462, 10.1159/000321365 · DOI
  51. Iorio, 2005, MicroRNA gene expression deregulation in human breast cancer, Cancer Res., 65, 7065, 10.1158/0008-5472.CAN-05-1783 · DOI · Paper page
  52. Izon, 1998, Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes, Blood, 92, 383, 10.1182/blood.V92.2.383 · DOI
  53. Jay, 2007, MiRNA profiling for diagnosis and prognosis of human cancer, DNA Cell Biol., 26, 293, 10.1089/dna.2006.0554 · DOI
  54. Jiang, 2006, Increased expression of microRNA-155 in Epstein–Barr virus transformed lymphoblastoid cell lines, Genes Chromosomes Cancer, 45, 103, 10.1002/gcc.20264 · DOI
  55. Jiang, 2010, MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene, Cancer Res., 70, 3119, 10.1158/0008-5472.CAN-09-4250 · DOI · Paper page
  56. Kasashima, 2004, Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells, Biochem. Biophys. Res. Commun., 322, 403, 10.1016/j.bbrc.2004.07.130 · DOI
  57. Kastner, 2008, PU.1: a crucial and versatile player in hematopoiesis and leukemia, Int. J. Biochem. Cell Biol., 40, 22, 10.1016/j.biocel.2007.01.026 · DOI · Paper page
  58. Kaufmann, 2005, MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution, Brain Dev., 27, 77, 10.1016/j.braindev.2004.10.008 · DOI
  59. Kawagoe, 1999, Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells, Leukemia, 13, 687, 10.1038/sj.leu.2401410 · DOI
  60. Keck-Wherley, 2011, Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes, Dev. Neurosci., 33, 451, 10.1159/000330884 · DOI
  61. Khvorova, 2003, Functional siRNAs and miRNAs exhibit strand bias, Cell, 115, 209, 10.1016/S0092-8674(03)00801-8 · DOI · Paper page
  62. Kim, 2009, Biogenesis of small RNAs in animals, Nat. Rev. Mol. Cell Biol., 10, 126, 10.1038/nrm2632 · DOI · Paper page
  63. Kluiver, 2005, BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas, J. Pathol., 207, 243, 10.1002/path.1825 · DOI
  64. Kluiver, 2006, Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma, Genes Chromosomes Cancer, 45, 147, 10.1002/gcc.20273 · DOI
  65. Kluiver, 2007, Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma, Oncogene, 26, 3769, 10.1038/sj.onc.1210147 · DOI
  66. Koch, 2012, Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis, Proc. Natl. Acad. Sci. U. S. A., 109, 1153, 10.1073/pnas.1116125109 · DOI
  67. Kohlhaas, 2009, Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells, J. Immunol., 182, 2578, 10.4049/jimmunol.0803162 · DOI
  68. Kong, 2008, MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA, Mol. Cell. Biol., 28, 6773, 10.1128/MCB.00941-08 · DOI
  69. Kong, 2010, MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer, J. Biol. Chem., 285, 17869, 10.1074/jbc.M110.101055 · DOI
  70. Kuhn, 2008, Experimental validation of miRNA targets, Methods, 44, 47, 10.1016/j.ymeth.2007.09.005 · DOI
  71. Ladoire, 2011, Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy, Breast Cancer Res. Treat., 125, 65, 10.1007/s10549-010-0831-1 · DOI
  72. Lagos-Quintana, 2002, Identification of tissue-specific microRNAs from mouse, Curr. Biol., 12, 735, 10.1016/S0960-9822(02)00809-6 · DOI · Paper page
  73. Lam, 2005, Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling, Clin. Cancer Res., 11, 28, 10.1158/1078-0432.28.11.1 · DOI
  74. Lau, 2001, An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans, Science, 294, 858, 10.1126/science.1065062 · DOI · Paper page
  75. Lawrence, 2005, Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells, Blood, 106, 3988, 10.1182/blood-2005-05-2003 · DOI
  76. Lee, 2007, Expression profiling identifies microRNA signature in pancreatic cancer, Int. J. Cancer, 120, 1046, 10.1002/ijc.22394 · DOI
  77. Leung, 2010, MicroRNA functions in stress responses, Mol. Cell, 40, 205, 10.1016/j.molcel.2010.09.027 · DOI · Paper page
  78. Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 · DOI · Paper page
  79. Li, 2012, miRNA-155 upregulation and complement factor H deficits in Down's syndrome, NeuroReport, 23, 168, 10.1097/WNR.0b013e32834f4eb4 · DOI
  80. Linnstaedt, 2010, Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein–Barr virus, J. Virol., 84, 11670, 10.1128/JVI.01248-10 · DOI · Paper page
  81. Liu, 2010, MicroRNA regulatory networks in cardiovascular development, Dev. Cell, 18, 510, 10.1016/j.devcel.2010.03.010 · DOI
  82. Liu, 2011, TNFa-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors, Biochem. Biophys. Res. Commun., 414, 618, 10.1016/j.bbrc.2011.09.131 · DOI
  83. Lu, 2008, Epstein–Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence, J. Virol., 82, 10436, 10.1128/JVI.00752-08 · DOI · Paper page
  84. Lu, 2009, Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein, Immunity, 30, 80, 10.1016/j.immuni.2008.11.010 · DOI
  85. Mao, 2011, In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination, Cell Biosci., 1, 3, 10.1186/2045-3701-1-3 · DOI
  86. Marson, 2007, Foxp3 occupancy and regulation of key target genes during T-cell stimulation, Nature, 445, 931, 10.1038/nature05478 · DOI · Paper page
  87. Masaki, 2007, Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis, Biochem. Biophys. Res. Commun., 364, 509, 10.1016/j.bbrc.2007.10.077 · DOI · Paper page
  88. Mathonnet, 2007, microRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F, Science, 317, 1764, 10.1126/science.1146067 · DOI
  89. Mattiske, 2012, The oncogenic role of miR-155 in breast cancer, Cancer Epidemiol. Biomarkers Prev., 21, 1236, 10.1158/1055-9965.EPI-12-0173 · DOI
  90. McCoy, 2010, IL-10 inhibits miR-155 induction by toll-like receptors, J. Biol. Chem., 285, 20492, 10.1074/jbc.M110.102111 · DOI
  91. McInnes, 2012, FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells, Oncogene, 31, 1045, 10.1038/onc.2011.293 · DOI
  92. Mendell, 2012, MicroRNAs in stress signaling and human disease, Cell, 148, 1172, 10.1016/j.cell.2012.02.005 · DOI · Paper page
  93. Miyoshi, 2010, Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production, Mol. Genet. Genomics, 284, 95, 10.1007/s00438-010-0556-1 · DOI
  94. Morgan, 2008, Sequence conservation and differential expression of Marek's disease virus microRNAs, J. Virol., 82, 12213, 10.1128/JVI.01722-08 · DOI
  95. Morrison, 1996, Low blood pressure in Down's syndrome: a link with Alzheimer's disease?, Hypertension, 28, 569, 10.1161/01.HYP.28.4.569 · DOI
  96. Muljo, 2005, Aberrant T cell differentiation in the absence of Dicer, J. Exp. Med., 202, 261, 10.1084/jem.20050678 · DOI
  97. Muller, 2009, Mutant p53 drives invasion by promoting integrin recycling, Cell, 139, 1327, 10.1016/j.cell.2009.11.026 · DOI · Paper page
  98. Mullokandov, 2012, High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries, Nat. Methods, 9, 840, 10.1038/nmeth.2078 · DOI · Paper page
  99. Neilsen, 2013, Mutant p53 drives invasion in breast tumors through up-regulation of miR-155, Oncogene J., 32, 2992, 10.1038/onc.2012.305 · DOI
  100. Nielsen, 2007, Determinants of targeting by endogenous and exogenous microRNAs and siRNAs, RNA, 13, 1894, 10.1261/rna.768207 · DOI
  101. Nikiforova, 2008, MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility, J. Clin. Endocrinol. Metab., 93, 1600, 10.1210/jc.2007-2696 · DOI
  102. O'Connell, 2007, MicroRNA-155 is induced during the macrophage inflammatory response, Proc. Natl. Acad. Sci. U. S. A., 104, 1604, 10.1073/pnas.0610731104 · DOI · Paper page
  103. O'Connell, 2008, Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder, J. Exp. Med., 205, 585, 10.1084/jem.20072108 · DOI · Paper page
  104. O'Connell, 2009, Inositol phosphatase SHIP1 is a primary target of miR-155, Proc. Natl. Acad. Sci. U. S. A., 106, 7113, 10.1073/pnas.0902636106 · DOI · Paper page
  105. Okamura, 2008, The regulatory activity of microRNA* species has substantial influence on microRNA and 3′ UTR evolution, Nat. Struct. Mol. Biol., 15, 354, 10.1038/nsmb.1409 · DOI · Paper page
  106. Pillai, 2005, Inhibition of translational initiation by let-7 microRNA in human cells, Science, 309, 1573, 10.1126/science.1115079 · DOI
  107. Ramkissoon, 2006, Hematopoieticspecific microRNA expression in human cells, Leuk. Res., 30, 643, 10.1016/j.leukres.2005.09.001 · DOI
  108. Ranganathan, 2012, Regulation of acute graft-versus-host disease by microRNA-155, Blood, 119, 4786, 10.1182/blood-2011-10-387522 · DOI
  109. Roizen, 2003, Down's syndrome, Lancet, 361, 1281, 10.1016/S0140-6736(03)12987-X · DOI
  110. Rüegger, 2012, MicroRNA turnover: when, how, and why, Trends Biochem. Sci., 37, 436, 10.1016/j.tibs.2012.07.002 · DOI
  111. Ruggiero, 2009, LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages, FASEB J., 23, 2898, 10.1096/fj.09-131342 · DOI
  112. Salmena, 2011, A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?, Cell, 146, 353, 10.1016/j.cell.2011.07.014 · DOI · Paper page
  113. Schwarz, 2003, Asymmetry in the assembly of the RNAi enzyme complex, Cell, 115, 199, 10.1016/S0092-8674(03)00759-1 · DOI · Paper page
  114. Scott, 2011, From snoRNA to miRNA: dual function regulatory non-coding RNAs, Biochimie, 93, 1987, 10.1016/j.biochi.2011.05.026 · DOI
  115. Sethupathy, 2007, Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes, Am. J. Hum. Genet., 81, 405, 10.1086/519979 · DOI
  116. Shanmugam, 1999, PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins, Mol. Cell. Biol., 19, 7577, 10.1128/MCB.19.11.7577 · DOI
  117. Shen, 1997, The Abd-B-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins, Mol. Cell. Biol., 17, 6448, 10.1128/MCB.17.11.6448 · DOI
  118. Shen, 1999, HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells, Mol. Cell. Biol., 19, 3051, 10.1128/MCB.19.4.3051 · DOI
  119. Shin, 2008, Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals, Mol. Cell, 26, 308, 10.1016/S1016-8478(23)14000-3 · DOI
  120. Skalsky, 2007, Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155, J. Virol., 81, 12836, 10.1128/JVI.01804-07 · DOI
  121. Stanczyk, 2008, Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum., 58, 1001, 10.1002/art.23386 · DOI
  122. Szafranska, 2007, MicroRNA expression alterations are linked to tumorigenesis and nonneoplastic processes in pancreatic ductal adenocarcinoma, Oncogene, 26, 4442, 10.1038/sj.onc.1210228 · DOI
  123. Tam, 2001, Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA, Gene, 274, 157, 10.1016/S0378-1119(01)00612-6 · DOI
  124. Tam, 1997, bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding. RNA, Mol. Cell. Biol., 17, 1490, 10.1128/MCB.17.3.1490 · DOI
  125. Tarassishin, 2011, Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*, Glia, 59, 1911, 10.1002/glia.21233 · DOI
  126. Thai, 2007, Regulation of the germinal center response by microRNA-155, Science, 316, 604, 10.1126/science.1141229 · DOI
  127. Thermann, 2007, Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation, Nature, 447, 875, 10.1038/nature05878 · DOI
  128. Thompson, 2011, NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway, J. Biol. Chem., 286, 1675, 10.1074/jbc.M110.177063 · DOI
  129. Tili, 2007, Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock, J. Immunol., 179, 5982, 10.4049/jimmunol.179.8.5082 · DOI · Paper page
  130. Tili, 2010, Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD, Carcinogenesis, 31, 1561, 10.1093/carcin/bgq143 · DOI
  131. van den Berg, 2003, High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma, Genes Chromosomes Cancer, 37, 20, 10.1002/gcc.10186 · DOI
  132. van Rooij, 2012, Developing microRNA therapeutics, Circ. Res., 110, 496, 10.1161/CIRCRESAHA.111.247916 · DOI · Paper page
  133. Vargova, 2011, MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia, Blood, 117, 3816, 10.1182/blood-2010-05-285064 · DOI
  134. Vigorito, 2007, microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells, Immunity, 27, 847, 10.1016/j.immuni.2007.10.009 · DOI
  135. Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc. Natl. Acad. Sci. U. S. A., 103, 2257, 10.1073/pnas.0510565103 · DOI · Paper page
  136. Wakiyama, 2007, Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system, Genes Dev., 21, 1857, 10.1101/gad.1566707 · DOI
  137. Wang, 2008, Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth, PLoS One, 3, e2557, 10.1371/journal.pone.0002557 · DOI
  138. Wang, 2010, Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1, J. Immunol., 185, 6226, 10.4049/jimmunol.1000491 · DOI · Paper page
  139. Wang, 2011, Oncogenic IRFs provide a survival advantage for Epstein–Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression, J. Virol., 85, 8328, 10.1128/JVI.00570-11 · DOI
  140. Westholm, 2011, Mirtrons: microRNA biogenesis via splicing, Biochimie, 93, 1897, 10.1016/j.biochi.2011.06.017 · DOI
  141. Worm, 2009, Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp beta and down-regulation of g-CSF, Nucleic Acids Res., 37, 5784, 10.1093/nar/gkp577 · DOI
  142. Wu, 2006, microRNAs direct rapid deadenylation of mRNA, Proc. Natl. Acad. Sci. U. S. A., 103, 4034, 10.1073/pnas.0510928103 · DOI
  143. Xiao, 2009, Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response, J. Infect. Dis., 200, 916, 10.1086/605443 · DOI · Paper page
  144. Yanaihara, 2006, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025 · DOI · Paper page
  145. Yang, 2011, Widespread regulatory activity of vertebrate microRNA* species, RNA, 17, 312, 10.1261/rna.2537911 · DOI · Paper page
  146. Yarden, 1999, BRCA1 interacts with components of the histone deacetylase complex, Proc. Natl. Acad. Sci. U. S. A., 96, 4983, 10.1073/pnas.96.9.4983 · DOI
  147. Yin, 2008, B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element, J. Biol. Chem., 283, 2654, 10.1074/jbc.M708218200 · DOI
  148. Yin, 2008, MicroRNA-155 is an Epstein–Barr virus-induced gene that modulates Epstein–Barr virus-regulated gene expression pathways, J. Virol., 82, 5295, 10.1128/JVI.02380-07 · DOI
  149. Zhang, 2012, LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas, Blood, 120, 1678, 10.1182/blood-2012-02-410647 · DOI
  150. Zhao, 2009, A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus, J. Virol., 83, 489, 10.1128/JVI.01166-08 · DOI
  151. Zhao, 2011, Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas, PLoS Pathog., 7, e1001305, 10.1371/journal.ppat.1001305 · DOI
  152. Zheng, 2010, MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts, Biochem. Biophys. Res. Commun., 400, 483, 10.1016/j.bbrc.2010.08.067 · DOI
  153. Zhou, 2010, miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells, Blood, 116, 5885, 10.1182/blood-2010-04-280156 · DOI · Paper page
  154. Zuo, 2007, FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2, J. Clin. Invest., 117, 3765

Cited by

Sorted by citations

See all 393

Metadata

Authors
Elton, T. S., Selemon, H., Elton, S. M., & Parinandi, N. L.
Venue
Gene
Publisher
Elsevier BV
Published
2013-12
Volume
532
Issue
1
Pages
1-12
ISSN
0378-1119
DOI
10.1016/j.gene.2012.12.009
Cited by
393
References
12
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of the MIR155 host gene in physiological and pathological processes. https://app.cochat.ai/papers/10.1016/j.gene.2012.12.009
The paper
Elton, T. S., Selemon, H., Elton, S. M., & Parinandi, N. L. (2013). Regulation of the MIR155 host gene in physiological and pathological processes. Gene. https://doi.org/10.1016/j.gene.2012.12.009